Atorvastatin magnesium trihydrate

This classification denotes a hmg-coa reductase inhibitor 2C33H34FN2O5.Mg.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S40X654V9C, chemically known as magnesium, bis((.beta.r,.delta.r)-2-(4-fluorophenyl)-.beta.-(hydroxy-.kappa.o)-.delta.-hydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoato-.kappa.o1)-, hydrate (1:3), (t-4)-, but more generally known as atorvastatin magnesium trihydrate, which bears US NIH Compound Identifier 24849182. European Medicines Agency schedules Atorvastatin magnesium trihydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37423. Most nations, for tariff and trade purposes, schedule atorvastatin magnesium trihydrate under HS 29339990 and SITC 51577. As of Q4 2014, ATORVASTATIN MAGNESIUM TRIHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.O.O.O.[MG+2].